Filing Details
- Accession Number:
- 0001140361-25-020159
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-22 16:05:39
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-22
- Accepted Time:
- 2025-05-22 16:05:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1281895 | Rocket Pharmaceuticals Inc. | RCKT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704342 | Martin Wilson | C/O Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury NJ 08512 | General Counsel | No | No | No | No |
Transaction Summary
Sold: | 587 shares | Avg. Price: $6.45 | Total Value: $3,783.80 |
Number of Shares After Transactions: | 149,163 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-20 | 587 | $6.45 | 149,163 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.